Biomerica Cash Flow - Quarterly (NASDAQ:BMRA)

Add to My Stocks
$3.37 $0.02 (0.59%) BMRA stock closing price Sep 19, 2018 (Closing)

The Biomerica cash flow statement is one of the important reports considered by investors doing a fundamental analysis of the company. The profit-loss statement shows Biomerica profits, the balance sheet shows Biomerica debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. Biomerica saw a cash impact of $1.29M from the issuance of BMRA shares. The cash flow statement helps in the Biomerica stock analysis by providing more information for evaluating changes in assets, liabilities and equities. Biomerica had an outflow of $-1.17M from operating activities, $1.29M inflow due to financing activities, and $-0.13M outflow due to investing activities till 2018 Q4.

View and download details of Biomerica cash flows for latest & last 40 quarters
show more
View Previous Quarters
View Next Quarters
Fiscal year is Jun - May2018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q3
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow----------
Net Increase (Decrease) in Assets Liabilities--0.2M---0.08M-0.04M-0.17M-0.05M--
Cash From (used in) Discontinued Operations----------
Other Adjustments Net--------0.01M--0.22M
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.13M-0.07M-0.05M-0.01M-0.09M-0.09M-0.02M--0.09M-0.06M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares1.29M-------1.1M-
Issuance (Repayment) of Debt Securities----------
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities----------
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash-0.01M-0.01M-0.01M-------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year1.23M1.88M1.08M1.5M2.46M1.07M-1.05M1.59M2.02M
Cash & Equivalents at Year End1.2M--1.08M1.22M1.54M1.61M1.81M1.88M-
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

While Biomerica stock price history provides the price history of a stock, Biomerica stock comparison chart shows the same in comparison to peers, and cash flow statements provide cash position of the company. Common terms used in the statement of cash flows are:

  • Biomerica saw a positive change in Net Change in Cash and Cash Equivalents of $-0.02M till 2018 Q4. Apart from the Biomerica stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Biomerica decreased its cash from operating activities to $-1.17M till 2018 Q4. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $-0.13M for BMRA till last quarter 2018 Q4 report.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $1.29M for Biomerica. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For Biomerica Cash Flow